Table 2.
SSRI/SNRI Luteal Phase or Symptom-Onset Dosing Showing Efficacy for Treatment of PMDD
Medication | Dose Range | Dosing Schedule |
---|---|---|
Sertraline | 50 mg to 100 mg daily30,31 | Luteal phase |
50 mg to 100 mg daily49 | Symptom-onset | |
Escitalopram | 10 mg to 20 mg daily32 | Luteal phase |
10 mg to 20 mg daily33 | Symptom-onset | |
Paroxetine | 10 mg to 20 mg daily36,37 | Luteal phase |
12.5 mg to 25 mg daily (controlled release)38–40 | ||
Fluoxetine | 10 mg to 20 mg daily41 | Luteal phase |
Venlafaxine | 75 mg to 112.5 mg daily51 | Luteal phase |